Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.160 | 6 | 26458037 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.780 | 1.000 | 8 | 2011 | 2014 | |||||||
|
6 | 26465807 | intron variant | A/C;G | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 2 | 2018 | 2019 | ||||||||||
|
1.000 | 0.080 | 6 | 26463346 | stop gained | G/A;T | snv | 4.5E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 6 | 26463432 | missense variant | G/A | snv | 5.7E-02 | 6.4E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
|
1.000 | 0.040 | 6 | 26466161 | intron variant | G/A | snv | 0.67 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 26466161 | intron variant | G/A | snv | 0.67 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
6 | 26466164 | intron variant | G/A;C | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.080 | 6 | 26468098 | missense variant | G/A;C | snv | 5.8E-02 | 6.4E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
|
1.000 | 0.040 | 6 | 26466954 | intron variant | T/C | snv | 0.31 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 6 | 26472427 | intron variant | A/G | snv | 0.48 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.160 | 6 | 26458037 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.030 | 1.000 | 3 | 2011 | 2014 | |||||||
|
0.827 | 0.160 | 6 | 26458037 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.030 | 1.000 | 3 | 2011 | 2015 | |||||||
|
0.827 | 0.160 | 6 | 26458037 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2011 | 2015 | |||||||
|
0.827 | 0.160 | 6 | 26458037 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.827 | 0.160 | 6 | 26458037 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2012 | 2014 | |||||||
|
0.827 | 0.160 | 6 | 26458037 | 5 prime UTR variant | T/C | snv | 0.70 |
|
0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.160 | 6 | 26458037 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.827 | 0.160 | 6 | 26458037 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.827 | 0.160 | 6 | 26458037 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 |